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Abstract. 
 
Microinjection of a truncated form of the c-kit 
tyrosine kinase present in mouse spermatozoa (tr-kit) 
activates mouse eggs parthenogenetically, and tr-kit–
induced egg activation is inhibited by preincubation with 
an inhibitor of phospholipase C (PLC) (Sette, C., A. 
Bevilacqua, A. Bianchini, F. Mangia, R. Geremia, and P. 
 
Rossi. 1997. 
 
Development [Camb.]
 
. 124:2267–2274). Co-
injection of glutathione-S-transferase (GST) fusion pro-
teins containing the src-homology (SH) domains of the 
 
g
 
1 isoform of PLC (PLC
 
g
 
1) competitively inhibits tr-kit–
induced egg activation. A GST fusion protein containing 
the SH3 domain of PLC
 
g
 
1 inhibits egg activation as 
efficiently as the whole SH region, while a GST fusion 
protein containing the two SH2 domains is much less ef-
fective. A GST fusion protein containing the SH3 
domain of the Grb2 adaptor protein does not inhibit 
tr-kit–induced egg activation, showing that the effect of 
the SH3 domain of PLC
 
g
 
1 is specific. Tr-kit–induced egg 
activation is also suppressed by co-injection of antibodies 
raised against the PLC
 
g
 
1 SH domains, but not against 
the PLC
 
g
 
1 COOH-terminal region. In transfected COS 
cells, coexpression of PLC
 
g
 
1 and tr-kit increases diacyl-
glycerol and inositol phosphate production, and the 
phosphotyrosine content of PLC
 
g
 
1 with respect to cells 
expressing PLC
 
g
 
1 alone. These data indicate that tr-kit 
activates PLC
 
g
 
1, and that the SH3 domain of PLC
 
g
 
1 is 
essential for tr-kit–induced egg activation.
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g
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A
 
fter
 
 sperm–egg fusion, sperm cytosolic factors are
released into the egg cytoplasm, and recent evi-
dence obtained in a number of animal systems
suggests that such a factor may trigger the series of events
culminating in cell cycle resumption and the first mitotic
division of the zygote (Stice and Robl, 1990; Swann, 1990;
Homa and Swann, 1994; Dozortsev et al., 1995; Wu et al.,
1997; Stricker, 1997). In many species, a series of Ca
 
2
 
1
 
transients is the early event triggered by the sperm at fer-
tilization (Whitaker and Swann, 1993), and the increase in
intracellular Ca
 
2
 
1
 
 is required for several of the events that
accompany egg activation (Kline and Kline, 1992). In the
mouse, it has been shown that sperm–egg fusion precedes
the onset of these Ca
 
2
 
1
 
 oscillations (Lawrence et al., 1997),
suggesting that a factor released by the sperm is responsi-
ble for the fertilization-associated Ca
 
2
 
1
 
 mobilization. How-
ever, the nature of such factor in mammals is still uncertain.
A possible candidate is oscillin, a glucosamine 6-phos-
phate deaminase that has been localized in the equatorial
segment of the hamster sperm head (Parrington et al.,
1996). However, whereas the protein fraction containing
oscillin induces Ca
 
2
 
1
 
 transients when microinjected into
mouse eggs (Parrington et al., 1996), neither recombinant
nor highly purified oscillin has oscillogenic activity, even
though they maintain glucosamine 6-phosphate deaminase
activity (Wolosker et al., 1998). Thus, it is possible that ei-
ther oscillin requires additional factors to elicit egg activa-
tion or a different protein of the sperm is responsible for
such function.
An additional candidate for a soluble sperm factor in-
ducing the early events of fertilization is tr-kit, an alterna-
tive product of the 
 
c-kit
 
 gene (Sette et al., 1997). Tr-kit is
encoded by an mRNA specifically expressed in the hap-
loid phase of mouse spermatogenesis (Sorrentino et al.,
1991; Rossi et al., 1992). Tr-kit mRNA is transcribed in
late spermiogenesis under the control of an intronic pro-
moter, as demonstrated by the tr-kit promoter driven ex-
pression of a reporter gene in transgenic mice (Albanesi
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et al., 1996). The open reading frame (ORF)
 
1
 
 of tr-kit en-
codes a 23-kD protein that contains only part of the cyto-
plasmic portion of the c-kit receptor tyrosine kinase (Rossi
et al., 1992). This region corresponds to the c-kit phospho-
transferase catalytic domain, but lacks the inter-kinase re-
gion, the ATP-binding site, the transmembrane and the
extracellular domains. The tr-kit protein has an apparent
molecular size of 24–28 kD, is expressed in elongating
spermatids (Albanesi et al., 1996), and immunofluores-
cence experiments indicate that it is localized in the resid-
ual cytoplasm of mouse epididymal spermatozoa (Sette et al.,
1997). We have previously reported that microinjection of
either lysates from cells expressing a recombinant tr-kit
protein or synthetic tr-kit RNA into metaphase II (MII)-
arrested mouse oocytes triggers the set of events associ-
ated with egg activation, from cortical granule exocytosis
to pronuclear formation and progression through cleavage
stages (Sette et al., 1997).
Tr-kit action is blocked by chelation of egg intracellular
Ca
 
2
 
1
 
 or by preincubation of eggs with an inhibitor of phos-
pholipase C (PLC) (Sette et al., 1997), suggesting that tr-
kit mediates Ca
 
2
 
1
 
 mobilization through activation of a
PLC isoform(s). PLCs are a family of enzymes that cata-
lyze hydrolysis of phosphatidylinositol 4,5 bisphosphate
(PIP
 
2
 
), with production of diacylglycerol (DAG) and inosi-
tol 1,4,5-trisphosphate (InsP
 
3
 
) (Berridge, 1993). DAG is a
powerful stimulator of various protein kinase C (PKC)
isoforms, and it has been suggested that PKC activity is re-
quired for sperm-induced egg activation (Colonna et al.,
1997; Gallicano et al., 1997
 
a,b
 
). On the other hand, InsP
 
3
 
binds to receptors coupled to channels responsible for the
release of Ca
 
2
 
1
 
 from intracellular stores (Berridge, 1993).
An increase in InsP
 
3
 
 production is required for the Ca
 
2
 
1
 
wave at fertilization in 
 
Xenopus
 
 oocytes (Nuccitelli et al.,
1993) and InsP
 
3
 
 receptors have been found to play an es-
sential role in mammalian egg activation at fertilization
(Miyazaki et al., 1992, 1993; Xu et al., 1994; Berridge,
1996). Furthermore, the involvement of InsP
 
3
 
 produced by
PLC in mammalian fertilization is also supported by the
observation that a PLC inhibitor can block the sperm-
induced Ca
 
2
 
1
 
 spiking at fertilization in mouse eggs (Du-
pont et al., 1996).
PLC
 
g
 
1 may represent the most likely PLC isoform in-
volved in tr-kit action inside the egg for the following rea-
sons: (
 
a
 
) PLC
 
g
 
1 has been shown by immunoblotting of
ovulated mouse oocytes (Dupont et al., 1996); (
 
b
 
) PLC
 
g
 
1
is activated after physical interaction with tyrosine kinases
(Lee and Rhee, 1995; Kamat and Carpenter, 1997; Rhee
and Bae, 1997), and it has been found to interact with the
activated c-kit receptor (Herbst et al., 1991; Lev et al.,
1991; Rottapel et al., 1991); (
 
c
 
) mutation of a tyrosine resi-
due (Y936) of the COOH-terminal portion of the human
c-kit receptor impairs association with PLC
 
g
 
1 (Herbst et al.,
1995), and the homologous residue is also present in the
 
mouse c-kit receptor (Y934) and in tr-kit (Y161); and (
 
d
 
) it
has been recently reported that PLC
 
g
 
 is essential for the
sperm-induced Ca
 
2
 
1
 
 mobilization at fertilization in starfish
eggs (Carroll et al., 1997).
Both physical interaction with tyrosine kinases and ty-
rosine phosphorylation of PLC
 
g
 
1 correlate with PLC
 
g
 
1
activation and subsequent stimulation of PIP
 
2
 
 hydrolysis
(Lee and Rhee, 1995; Kamat and Carpenter, 1997; Rhee
and Bae, 1997). In addition to catalytic domains, PLC
 
g
 
1
contains several regulatory regions, and in particular src-
homology 2 (SH2) and SH3 domains, which mediate its in-
teraction with upstream and downstream effectors (Cohen
et al., 1995; Pawson, 1995). The SH2 domains of the protein
directly bind specific phosphotyrosine residues present in
cytoplasmic domains of receptor tyrosine kinases (RTKs)
(Mohammadi et al., 1991), whereas the targets of the SH3
domain are proline-rich sequences present in proteins
such as the microtubule-associated GTPase dynamin
(Gout et al., 1993).
In the present study, we demonstrate that PLC
 
g
 
1 is ac-
tually involved in tr-kit–induced parthenogenetic egg acti-
vation and that the SH3 domain of PLC
 
g
 
1 is essential for
this process. Using biochemical approaches in transfected
COS cells, we also show that coexpression of PLC
 
g
 
1 and
tr-kit stimulates an increase in tyrosine phosphorylation of
PLC
 
g
 
1, together with production of DAG and inositol
phosphates (InsPs). These data strongly suggest that the
mechanism of mouse egg activation triggered by tr-kit mi-
croinjection involves PLC
 
g
 
1-mediated hydrolysis of PIP
 
2
 
.
 
Materials and Methods
 
Expression of Recombinant Tr-kit Protein
 
Subconfluent COS cell monolayers were cultured in 90-mm dishes (Corn-
ing Glass Works, Corning, NY) and processed for CaPO
 
4
 
 transfection
with either 20 
 
m
 
g of the pCMV5 eukaryotic expression vector containing
the tr-kit cDNA (pCMV5-tr-kit) or no DNA (mock) as previously de-
scribed (Albanesi et al., 1996). 48 h after transfection, mock- and tr-kit–
transfected COS cells were harvested in microinjection buffer (20 mM
Hepes, pH 7.5, 120 mM KCl, 0.1 mM EGTA, 10 mM 
 
b
 
-glycerophosphate,
10 
 
m
 
g/ml leupeptin, 10 
 
m
 
g/ml aprotinin), homogenized, and then centri-
fuged for 10 min at 14,000 
 
g
 
 at 4
 
8
 
C. Aliquots of supernatant fractions were
immediately frozen at 
 
2
 
80
 
8
 
C. Tr-kit expression was monitored by West-
ern blot analysis before microinjection experiments.
 
Quantification of Tr-kit in Mouse Spermatozoa and in 
COS Cell Extracts
 
Spermatozoa from the cauda of the epididymis of 12- to 15-wk-old CD1
mice were collected in MEM (GIBCO BRL, Gaithersburg, MD) supple-
mented with 30 mg/ml BSA (Sigma Chemical Co., St. Louis, MO). After a
2-h incubation at 37
 
8
 
C, spermatozoa were collected by centrifugation at
3,000 
 
g
 
 at 4
 
8
 
C, washed twice with PBS, and then lysed in SDS-PAGE sam-
ple buffer. Lysates were sonicated, for three cycles of 20 s at 4
 
8
 
C, boiled
for 5 min, and then centrifuged for 10 min at 10,000 
 
g 
 
at 4
 
8
 
C. Soluble ma-
terial was analyzed by Western blot.
Cell lysate from 3 
 
3 
 
10
 
6
 
 spermatozoa and 50 
 
m
 
g of proteins from mock-
and tr-kit–transfected COS cell extracts were separated on a 10% SDS-
PAGE gel under denaturing conditions, blotted onto a nitrocellulose
membrane, and then analyzed by Western blot using an anti–c-kit anti-
body as described below. Intensity of the bands corresponding to tr-kit
were quantified by optical densitometry using the Molecular Analyst pro-
gram and a GS-700 Imaging Densitometer (Bio-Rad Laboratories, Her-
cules, CA). 50 
 
m
 
g of tr-kit–transfected COS cell extracts contained an
amount of tr-kit threefold higher than that present in 3 
 
3 
 
10
 
6
 
 spermatozoa
(see Fig. 1). In microinjection experiments we injected 5 pl of a 0.2–0.4 
 
m
 
g/
 
m
 
l
 
1. 
 
Abbreviations used in this paper
 
: DAG, diacylglycerol; GST, glu-
tathione-S-transferase; InsP, inositol phosphate; InsP
 
3
 
, inositol 1,4,5-tris-
phosphate; MII, metaphase II; NRTK, non-receptor tyrosine kinase; PIP
 
2
 
,
phosphatidylinositol-4,5-bisphosphate; PIP
 
3
 
, phosphatidylinositol-3,4,5-
trisphosphate; PKC, protein kinase C; PLC, phospholipase C; RTK, re-
ceptor tyrosine kinase; SCF, stem cell factor; SH, src-homology; SH2, src-
homology 2; SH3, src-homology 3; tr-kit, truncated c-kit. 
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solution of tr-kit cell extracts (1–2 pg of proteins), an amount correspond-
ing to 0.2–0.4 sperm equivalents of tr-kit.
 
Oocyte Collection, Microinjection and In Vitro Culture
 
MII-arrested oocytes were collected from hormonally primed (Hogan et al.,
1994) 4- to 6-wk-old CD1 female mice (Charles River, Calco, Italia) 15 h
after hCG (Sigma Chemical Co.) injection. Ovulated oocytes were freed
from cumulus cells by a brief incubation in 0.5 mg/ml hyaluronidase
(Sigma Chemical Co.) in M2 medium (Hogan et al., 1994), washed with
M2 medium, and then immediately processed for microinjection as de-
scribed (Sette et al., 1997). Groups of 20 MII oocytes were transferred to
50-
 
m
 
l drops of M2 under mineral oil (Sigma Chemical Co.) and subjected
to intracytoplasmic injections using a Nikon invertoscope (Nikon Corp.,
Tokyo, Japan) equipped with Hoffman modulation contrast optics (Mod-
ulation Optics, Inc., Greenvale, NY) and two Leitz mechanical microma-
nipulators (Leica AG, Heerbrugg, Switzerland).
 
 
 
A quantification of the
approximate volume of solution microinjected into a single oocyte, was
performed in repeated experiments as follows: a known amount of injec-
tion solution (usually 100 pl) was drawn in the injection pipette and used
completely for a series of microinjections under the same routinary condi-
tions. The average number of oocytes microinjected with 100 pl of solu-
tion was 17. Considering the loss of small amounts of solution between in-
jections, the injected volume per oocyte was 
 
z
 
5 pl.
 
 
 
After injection,
surviving oocytes were cultured at 37
 
8
 
C in M16 medium (Hogan et al.,
1994) under a humidified atmosphere of 5% CO
 
2
 
 in air for 
 
#
 
7 h, and then
scored for pronuclei formation by phase-contrast microscopy. To confirm
the score, in most experiments eggs were fixed in 4% PFA in PBS 7 h after
the injection, and stained with 10 
 
m
 
g/ml Hoechst 33342 (Sigma Chemical
Co.) for 5 min. After five washes in M2, eggs were mounted in 30% glyc-
erol in PBS on glass slides with coverslip compression, sealed, and then
analyzed by fluorescence microscopy.
For cortical granule staining, microinjected eggs were fixed after 1–4 h,
and processed as described below.
 
Cortical Granule and Chromosome Staining
 
1–4 h after microinjection, cultured oocytes were freed from the zona pel-
lucida by acidic tyrode solution (Hogan et al., 1994) and fixed in 4% PFA
in PBS for 30 min at room temperature. After three washes in M2 (block-
ing solution), oocytes were incubated with 0.1% Triton X-100 in the same
medium for 5 min and transferred to blocking solution for 60 min at room
temperature. Oocytes were then treated for 60 min at room temperature
with 0.1 mg/ml TRITC-labeled lectin from Lens Culinaris (Sigma Chemi-
cal Co.) in blocking solution (Ducibella et al., 1988), washed four times for
5 min in blocking solution, incubated for 5 min with 10 
 
m
 
g/ml Hoechst
33342 dye in blocking solution, and washed again. Oocytes were then
mounted in 30% glycerol in PBS as described above and analyzed by fluo-
rescence microscopy.
 
Glutathione-S-Transferase–PLC
 
g
 
1 Fusion Proteins and 
Antibodies Used in Microinjection Experiments
 
The glutathione-S-transferase (GST)-encoding plasmid pGEX3X was ob-
tained from Pharmacia Biotech, Inc. (Piscataway, NJ). Plasmid DNAs en-
coding for GST fusion proteins of bovine PLC
 
g
 
1 SH2–SH2 and human
PLC
 
g
 
1 SH3 (see Fig. 3) in pGEX2T
 
9
 
6 were a kind gift from S. Court-
neidge (Sugen, Inc., Redwood City, CA).
Affinity-purified GST-PLC
 
g
 
1 SH region fusion protein (GST-PLC
 
g
 
1-
SH2SH2SH3) (No. sc4019), and GST-Grb2-SH3 (residues 156–199; No.
sc4036) were obtained from Santa Cruz Biotechnology (Santa Cruz, CA).
Control GST protein, GST-PLC
 
g
 
1 SH2-SH2, and GST-PLC
 
g
 
1 SH3 fu-
sion proteins were produced as described by Gish et al. (1995), affinity pu-
rified on glutathione Sepharose, extensively dialyzed against PBS, and
concentrated to 10 mg/ml using a 10-kD cutoff Centricon (Millipore
Corp., Bedford, MA). Protein concentration was determined according to
Bradford (1976) using BSA as a standard.
The anti-PLC
 
g
 
1bd antibody (No. 426; Santa Cruz Biotechnology) consists
of affinity-purified rabbit polyclonal IgGs directed against the SH region of
rat PLC
 
g
 
1 (“binding domain”; amino acids 530–850). The anti-PLC
 
g
 
1ct anti-
body (No. 81; Santa Cruz Biotechnology) consists of affinity-purified rabbit
polyclonal IgGs directed against a peptide in the COOH terminus of bovine
PLC
 
g
 
1 (amino acids 1,249–1,262). Both antibodies recognize mouse PLC
 
g
 
1
in Western blot and immunoprecipitation and do not cross-react with other
PLC isoforms. As a control, affinity-purified normal rabbit IgGs were used.
For tr-kit co-injection experiments in mouse eggs, GST fusion proteins
were diluted in the injected solution to 500 
 
m
 
g/ml, whereas affinity-puri-
fied rabbit polyclonal IgGs were diluted to 10 
 
m
 
g/ml. Since we injected 5 pl
of protein solution in the oocytes, considering the average volume of
mouse eggs equal to 270 pl, the final concentration inside the injected eggs
of all microinjected proteins was 
 
z
 
50-fold lower (10 
 
m
 
g/ml for the GST fu-
sion proteins and 0.2 
 
m
 
g/ml for the antibodies), unless otherwise specified
in the Results section. Control experiments using the Santa Cruz glycerol
buffer (vehicle of GST fusion proteins) in addition to tr-kit did not inter-
fere with egg activation (Sette, C., and A. Bevilacqua, unpublished obser-
vations).
 
Measurement of DAG and InsP Production in
COS Cells
 
For measurement of DAG production, subconfluent COS cell monolayers
in 90-mm dishes were processed for CaPO
 
4
 
 transfection with either 20 
 
m
 
g
pRK-PLCg1 (expression vector for PLCg1, a generous gift from Dr. A.
Ullrich, Max-Planck Institut, Martinsried, Germany) alone, or with 20 mg
pRK-PLCg1 and 20 mg pCMV5-tr-kit (see Albanesi et al., 1996). 18 h af-
ter transfection, cells were washed with PBS and cultured for additional
2 h in DME containing 10% FCS (GIBCO-BRL) and 0.5 mCi/ml
[3H]arachidonic acid. At the end of the incubation, cells were washed
twice with cold PBS and harvested in 0.5 ml PBS/dish. The pH of the cell
suspensions was lowered to 2–3 by addition of HCl (30 mM final concen-
tration). Lipids were extracted by addition of 4 vol of chloroform/metha-
nol (1:2) in glass tubes according to the method of Boukhchache and
Lagarde (1982). Neutral lipids were separated by thin layer chromatogra-
phy on silicagel plates (Merck, Darmstadt, Germany) using a solution of
hexane/diethyl ether/acetic acid (50:50:1) for the migration. Plates were
stained with 0.3 mg/ml Coomassie brilliant blue R250 (Bio-Rad Laborato-
ries) in 0.15 M NaCl containing 20% methanol. The DAG bands were
identified on the plates based on the migration of known lipid standards
(Sigma Chemical Co.), scraped off, mixed with Picofluor (Packard), and
their radioactivity was determined by liquid scintillation counting. DAG-
associated radioactivity was expressed as cpm incorporated in DAG
versus 103 CPM incorporated in total lipids (neutral lipids bands plus
phospholipids at the origin of the chromatogram). DAG-associated radio-
activity ranged between 1,200 and 3,000 cpm; the average amount of CPM
in total lipids was z200,000.
For measurement of InsPs production, subconfluent COS cell mono-
layers in 35-mm dishes were transfected with either 4 mg pRK-PLCg1
alone, or 4 mg pRK-PLCg1 and 4 mg pCMV5-tr-kit. Immediately after
transfection cells were transferred to DME containing 10% FCS and 5
mCi/ml D-myo-[3H]inositol, and cultured for additional 12–24 h. We se-
lected two time points after transfection (12 and 24 h) to investigate
whether cells had reached steady state of phosphoinositides labeling and
InsPs accumulation. The tr-kit–induced InsPs accumulation measured
at 24 h is only slightly higher than that observed at 12 h, suggesting that
cells had reached steady-state levels. During the final 60 min of incuba-
tion, 10 mM LiCl was added to the medium. Incubation was stopped by
washing three times with PBS and adding ice-cold 10% TCA to the cells.
[3H]Inositol-labeled InsPs were extracted, separated by ion exchange
chromatography on Dowex 138-200 and counted as described by Adamo
et al. (1985). InsPs were expressed as cpm incorporated in InsPs fractions
per mg of total protein resuspended after TCA precipitation.
Immunoprecipitation and GST-PLC
Coprecipitation Experiments
Subconfluent COS cell monolayers in 90-mm dishes were processed for
CaPO4 transfection with the appropriate plasmids as described above.
Cells transfected with pCMV5-c-kit (obtained by subcloning c-kit cDNA
from pCDM8-c-kit [a generous gift from Dr. P. Besmer, Sloan Kettering
Cancer Center, New York, NY] into pCMV5) were treated for 10 min
with or without 100 ng/ml stem cell factor (SCF) in the presence of 250
mM sodium orthovanadate in complete medium before harvesting. 24 h
after transfection, cells were rinsed with PBS, harvested in lysis buffer (50
mM Hepes, pH 7.5, 150 mM NaCl, 15 mM MgCl2, 15 mM EGTA, 250 mM
sodium orthovanadate, 10% glycerol, 1% Triton X-100, 0.1% SDS, 10 mg/
ml leupeptin, 10 mg/ml aprotinin, 10 mg/ml pepstatin), and incubated on
ice for 5 min. Detergent-soluble extracts were separated by 10-min centrif-
ugation at 15,000 g at 48C.
For immunoprecipitation experiments, either a rabbit anti-kit antise-
rum raised against the 13 COOH-terminal amino acids common to theThe Journal of Cell Biology, Volume 142, 1998 1066
mouse c-kit and tr-kit proteins (1:100 dilution; Albanesi et al., 1996) or a
mixture of 1 mg anti-PLCg1bd and 1 mg anti-PLCg1ct IgGs were preincu-
bated for 60 min with protein A–Sepharose beads (Sigma Chemical Co.).
At the end of the incubation, the beads were washed once with 20 mM
Tris-HCl, pH 7.8, containing 0.5 M NaCl, twice with 20 mM Tris-HCl, pH
7.8, and then incubated for 90 min at 48C with the detergent-soluble ex-
tracts under constant shaking. Protein A–Sepharose–bound immunocom-
plexes were rinsed three times with PBS containing 0.05% BSA, twice
with PBS, and finally eluted in SDS-PAGE sample buffer (62.5 mM Tris-
HCl, pH 6.8, 10% glycerol, 2% (wt/vol) SDS, 0.7 M 2-mercaptoethanol,
and 0.0025% (wt/vol) bromophenol blue). For GST-PLC coprecipitation
experiments, 10 mg of affinity-purified GST-PLC (SH2-SH2-SH3) protein
were added to detergent-soluble extracts. After 30 min, samples were incu-
bated with glutathione–agarose beads for additional 90 min at 48C under
constant shaking. At the end of the incubation, glutathione-agarose–bound
protein complexes were rinsed three times with PBS before elution in 50
mM Tris-HCl, pH 8.0, containing 5 mM reduced glutathione. Eluted pro-
teins were diluted in SDS-PAGE sample buffer for Western-blot analysis.
Western Blot Analysis
For detection of recombinant proteins, samples from transfected cells,
from immunoprecipitation, and from coprecipitation with GST-PLC pro-
tein, were separated on 10% SDS-PAGE, transferred onto nitrocellulose
membrane (Amersham) and subjected to Western blot analysis with dif-
ferent antibodies as previously described (Albanesi et al., 1996). In brief,
first antibody incubation (90 minutes at room temperature) was carried
out with 1:1,000 dilution of a polyclonal anti-kit antiserum (Albanesi et al.,
1996), or affinity-purified polyclonal anti-PLCg1bd IgGs described above,
or affinity-purified mouse anti-phosphotyrosine mAb (No. 508, Santa
Cruz Biotechnology). Second antibody incubation was carried out with
1:10,000 dilution of either anti-rabbit or anti-mouse IgGs antibody conju-
gated to horseradish peroxidase (Amersham Corp., Arlington Heights,
IL). Immunostained bands were detected by the enhanced chemilumines-
cence method (Amersham Corp.). Tyrosine phosphorylation of immuno-
precipitated PLCg1 was quantified as the ratio of the optical density de-
tected by the anti-phosphotyrosine antibody (aPY) versus that detected by
the anti-PLCg1 antibody (aPLCg1) (mean 6 SD of six separate experi-
ments). Optical Densitometry was performed using the Molecular Analyst
program and a GS-700 Imaging Densitometer (Bio-Rad Laboratories).
Results
Kinetics of Tr-kit–induced Parthenogenetic Activation 
of Mouse Eggs
We have previously shown that microinjection of either
cell extracts expressing recombinant tr-kit or synthetic tr-
kit mRNA is able to induce complete parthenogenetic acti-
vation of mouse eggs and cleavage to the two-cell stage
(Sette et al., 1997). To compare the amount of recombinant
tr-kit capable of activating mouse eggs with the amount
carried by a single mouse sperm, we performed Western
blot analysis (Fig. 1). Densitometric analysis of immuno-
reactive bands indicated that the amount of tr-kit protein
obtained from extracts of 3 3 106 sperm was nearly three-
fold smaller than that from 50 mg of extracts of tr-kit–
expressing COS cells (see also Materials and Methods). As
shown in Fig. 2 and Table I, injection of z0.2–0.4 sperm
equivalents of recombinant tr-kit is sufficient to exert acti-
vation of 60–70% mouse eggs. Injection of z0.1 sperm
equivalents of tr-kit reduced the activation rate to 40–50%,
and injection of z0.01 sperm equivalents did not result in
significant activation of mouse eggs above the background
reported in Table I (not shown). Although the timing of egg
activation triggered by microinjection of recombinant tr-kit
is not completely synchronous, the typical time course and
pattern of the cell cycle events (Fig. 2) closely resemble
those observed at fertilization of the mouse eggs (Mori et
al., 1988). 1 h after injection, 60–70% of the eggs underwent
metaphase–anaphase transition and initiated polar body ex-
trusion (Fig. 2, A and B). At 4 h, the polar body was ex-
truded in all activated eggs, chromosome decondensation
had begun and an incipient pronucleus was evident (Fig. 2
C). The size of the pronucleus progressively increased from
the time of appearance to reach its full size after 6–7 h from
the injection in all the activated eggs (Fig. 2 D).
A GST Fusion Protein Containing the
PLCg1-SH3 Domain Inhibits Tr-kit–induced
Parthenogenetic Activation of Mouse Eggs
To test the hypothesis that PLCg1 is involved in tr-kit–
induced parthenogenetic activation of mouse eggs, we sub-
jected MII-arrested oocytes, which express PLCg1 (Fig. 3
A; Dupont et al., 1996), to co-injection of extracts from
COS cells expressing a recombinant tr-kit protein, and a
purified GST fusion protein containing the entire SH2-
SH2-SH3 region of PLCg1 (GST-PLCg1-SH2SH2SH3)
(Fig. 3 B). The SH region mediates interaction of PLCg1
with proteins involved in enzyme regulation (Lee and
Rhee, 1995; Kamat and Carpenter, 1997; Rhee and Bae,
1997), and competition to this region of PLCg1 has been
shown to prevent enzyme activation (Chen et al., 1994).
Injection of recombinant tr-kit alone, or co-injection of tr-
kit together with a control GST protein resulted in activa-
tion of 63–70% of the eggs, as monitored by formation of a
pronucleus 4–7 h after injection (Table I). Co-injection of
tr-kit and GST-PLCg1-SH2SH2SH3 significantly reduced
the activation rate to 15%, suggesting a role of PLCg1 in
tr-kit action in the egg cytoplasm. Only 5–8% of spontane-
ous activation was obtained in either non-injected eggs
(Table I) or in eggs injected with extract from mock-trans-
fected cells (data not shown; Sette et al., 1997).
To further investigate which SH domain of PLCg1 is in-
volved in tr-kit–induced egg activation, we co-injected tr-
kit with GST fusion proteins containing either the tandem
SH2 domains (GST-PLCg1-SH2SH2) or the SH3 domain
(GST-PLCg1-SH3) of the protein (Fig. 3). Co-injection of
GST-PLCg1-SH2SH2 only slightly reduced tr-kit–induced
egg activation (53% versus 70%; Table I). However, co-
injection of GST-PLCg1-SH3 inhibited egg activation as
efficiently as the entire SH2-SH2-SH3 region, reducing the
activation rate to 14% (Table I). Since we have previously
reported that tr-kit–induced egg activation is also associ-
Figure 1. Quantitative analysis of
recombinant tr-kit microinjected
into MII-arrested mouse oocytes.
Western blot analysis with an anti–
c-kit antibody was performed on 25
ml (50 mg of total proteins) of ex-
tracts from COS cells expressing re-
combinant tr-kit or on extracts from
3 3 106 sperms. The expected major
immunoreactive band of z28 kD
was present in both samples in a 3:1
ratio (see Materials and Methods).
Since in our microinjection experi-
ments we inject into mouse eggs
z1–2 pg of proteins from extracts of tr-kit–expressing COS cells,
we can calculate that we inject between 0.2 and 0.4 sperm equiva-
lents of recombinant tr-kit. This experiment was performed twice
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ated with early events of egg activation, such as the Ca21-
dependent cortical granules (CGs) exocytosis (Sette et al.,
1997), the effect of the GST-PLCg1 SH2 and SH3 fusion
proteins on CGs release was investigated. Co-injection of
GST-PLCg1-SH3 inhibited both cortical granule release
(Fig. 4 A) and polar body extrusion (not shown) with a rate
similar to that observed for pronuclear formation (Fig. 4 A;
see Table I for rate of inhibition) while the GST-PLCg1-
SH2SH2 protein was much less effective (Fig. 4 B; see Table
I for rate of inhibition). Co-injection of 10-fold diluted GST-
PLCg1-SH3, at a final concentration in the egg of z1 mg/ml,
resulted in an almost equally efficient inhibition of tr-kit–
induced pronuclear formation (Table I). To test for the spec-
ificity of the SH3 domain of PLCg1, we co-injected tr-kit to-
gether with a GST fusion protein containing the SH3
domain of the adaptor protein Grb2. Although the SH3 do-
mains of Grb2 and PLCg1 can bind to common targets, such
as dynamin (Gout et al., 1993), they have been reported to
direct the corresponding GST fusion proteins to different
cell compartments when microinjected in NIH3T3 fibro-
blasts (Bar-Sagi et al., 1993), implying that the Grb2 and
PLCg1 SH3 domains can also recognize different targets. As
shown in Table I, co-injection of GST-Grb2-SH3 was not
able to affect tr-kit–induced egg activation. These data indi-
cate that competition for targets of the SH3 domain specific
to PLCg1 impairs tr-kit–induced egg activation.
An Antibody Directed Against the SH2-SH2-SH3 
Region of PLCg1 Blocks Tr-kit–induced Activation of 
Mouse Eggs
The role of the SH region of PLCg1 in tr-kit–mediated egg
activation was also investigated by microinjection experi-
ments using antibodies raised against different regions of
PLCg1. The anti-PLCg1bd antibody is directed against the
SH region of PLCg1 and we hypothesized that its binding
would prevent PLCg1 interaction with effector proteins.
The anti-PLCg1ct antibody is directed against the COOH
terminus of PLCg1, a region of the enzyme that is not
known to be involved in catalytic activity and/or interac-
tion of PLCg1 with other proteins (Lee and Rhee, 1995).
These antibodies are specific for PLCg1, and they do not
cross-react with other PLC isoenzymes. The anti-PLCg1bd
(Fig. 3 A) and the anti-PLCg1ct antibodies (not shown)
recognize PLCg1 in Western blots from extracts of both
PLCg1-overexpressing COS cells and of MII-arrested
mouse oocytes. Microinjection experiments showed that
the anti-PLCg1bd antibody almost completely suppresses
Figure 2. Time-course of the cell cycle events
induced by microinjection of recombinant tr-kit
into MII-arrested mouse oocytes. This pattern
was constantly observed in the tr-kit–activated
oocytes. Eggs were fixed and stained with
Hoechst (10 mg/ml) either before microinjection
(A), or after increasing times from microinjection
of extracts from COS cells expressing tr-kit (200
mg/ml), 1 h (B), 4 h (C), and 6 h (D). Bar, 30 mm.
Table I. A GST-PLCgl-SH3 Domain Fusion Protein 
Specifically Inhibits Tr-kit–induced Parthenogenetic Activation 
of Mouse Eggs
Sample
No. of
experiments Total eggs
Pronuclei
formed
Percent
Activated eggs
Non-injected 9 80 4 5***
Tr-kit 16 118 75 63.5
Tr-kit1GST 4 20 14 70.0*
Tr-kit1PLCg1SH2SH2SH3 4 46 7 15.2***
Tr-kit1PLCg1SH2SH2 6 41 21 53.8**
Tr-kit1PLCg1SH3 6 56 8 14.2***
Tr-kit1PLCg1SH3 (1 mg/ml) 3 35 7 20.0***
Tr-kit1Grb2SH3 3 24 16 66.6*
Summary of microinjection experiments using 5 pl of extracts (200–400 mg/ml) from
tr-kit–transfected COS cells (tr-kit) alone or plus GST (tr-kit1GST), or plus GST-
PLCg1-SH2SH2SH3 (tr-kit1PLCg1SH2SH2SH3), or plus GST-PLCg1-SH2SH2
(tr-kit1PLCg1SH2SH2), or plus GST-PLCg1-SH3 (tr-kit1PLCg1SH3), or plus
GST-Grb2-SH3 (tr-kit-Grb2SH3). Final concentration of all co-injected GST fusion
proteins inside the egg was 10 mg/ml. GST-PLCg1-SH3 was also tested at a 10-fold
lower concentration (1 mg/ml). Pronuclear formation was scored 4–7 h after microin-
jection by phase-contrast microscopy. In most experiments pronuclear formation was
confirmed by Hoechst staining. Statistical analysis (ANOVA test) was performed us-
ing program PSI-plot 3.0 from Polysoftware International (P values vs. tr-kit: *P .
0.5; ** P , 0.05; *** P , 0.0001).The Journal of Cell Biology, Volume 142, 1998 1068
tr-kit–induced mouse egg activation, resembling the effect
obtained by co-injection of tr-kit and either the GST-PLCg1-
SH2SH2SH3 or the GST-PLCg1-SH3 fusion proteins,
whereas nonimmune antibodies at the same concentration
are ineffective (Table II). On the other hand, co-injection of
recombinant tr-kit and the anti-PLCg1ct antibody did not
significantly inhibit egg activation, showing that binding of
antibodies to the COOH terminus of PLCg1 does not impair
interaction with factors required for egg activation (Table II).
The inhibition obtained with the anti-PLCg1bd antibody
confirms that PLCg1 is involved in parthenogenetic egg acti-
vation triggered by tr-kit and that an essential role in such
pathway is played by the SH region of PLCg1.
Tr-kit Stimulates PIP2 Hydrolysis in Transfected
COS Cells
The ability of tr-kit to stimulate the catalytic activity of
PLCg1 was investigated by cotransfection experiments in
COS cells. Cells were transfected with a tr-kit expression
Figure 3. Expression of PLCg1 in MII-arrested
mouse eggs, and schematic representation of the
bacterial fusion proteins containing different
PLCg1 domains. In the schematic representation
of PLCg1 on the top of this figure, brackets iden-
tify the regions of PLCg1 recognized by the two
antibodies used for microinjection experiments
shown in Table II. PH, pleckstrin homology do-
main; Ca21, EF-hand domain (calcium binding
motif); X and Y, split catalytic domain; P and H,
split pleckstrin homology domain; SH2 and SH3,
src-homology domains; C2, Ca21-dependent lipid
binding domain. (A) Western blot from extracts
of COS cells transfected with a PLCg1 expres-
sion vector (50 mg), and from extracts of 50
mouse eggs, probed with the anti-PLCg1bd anti-
body, described in the Materials and Methods
section, and used for the microinjection experi-
ments shown in Table II. (B) Bacterial fusion
proteins containing different PLCg1 domains used for the experiments shown in Table I. The Coomassie blue staining of a 10% SDS-
PAGE gel loaded with affinity-purified GST fusion proteins is shown on the right: lane 1, GST; lane 2, GST-PLCg1-SH2SH2SH3; lane
3, GST-PLCg1-SH2SH2; lane 4, GST-PLCg1-SH3.
Figure 4. The SH3 domain, and not the SH2 do-
mains, of PLCg1 inhibits tr-kit–induced cortical
granules exocytosis and pronuclear formation in
mouse eggs. Eggs were co-injected with cell ex-
tracts (200 mg/ml) containing recombinant tr-kit
and 500 mg/ml (final concentration in the egg:
z10 mg/ml) of either GST-PLCg1-SH3 (A) or
GST-PLCg1-SH2SH2 (B) and fixed 4 h after in-
jection. Tr-kit–induced cortical granule reaction
was inhibited by co-injection of GST-PLCg1-
SH3, but not by GST-PLCg1-SH2SH2, with a
similar rate as for pronuclear formation (see Ta-
ble I) in three separate experiments. Double
staining of chromatin (Hoechst dye) and cortical
granules (TRITC-labeled lectin) was performed
as described under Materials and Methods. Bar,
30 mm.Sette et al. PLCg1 Involvement in Tr-kit–induced Egg Activation 1069
vector, or with a PLCg1 expression vector, or cotrans-
fected with both plasmids, labeled with either [3H]arachi-
donic acid or [3H]inositol, and processed for assays of dia-
cylglycerol production or InsP production, respectively.
As shown in Fig. 5 A, when cells were transfected with
tr-kit alone, a slight increase in DAG production was ob-
served, likely indicating activation of endogenous PLCs.
As expected, an increase in DAG production was also ob-
served in cells transfected with PLCg1 versus mock-trans-
fected cells. Coexpression of tr-kit and PLCg1 was repro-
ducibly accompanied by a much higher activation of DAG
production, suggesting that, in cotransfection experiments,
tr-kit is able to stimulate DAG production by activating
PLCg1. Cotransfection of PLCg1 with the full-length c-kit
receptor did not induce any increase in DAG production
with respect to cells transfected with PLCg1 alone. More-
over, stimulation of c-kit–transfected cells with the c-kit
ligand (SCF) did not induce any increase in DAG produc-
tion with respect to both unstimulated cells and cells trans-
fected with PLCg1 alone (Fig. 5 A), even though PLCg1
associates with c-kit after SCF stimulation (see below, Fig.
7 A). The inability of autophosphorylated c-kit to activate
PLCg1 is in agreement with our previous observation that
SCF treatment fails to activate MII-arrested oocytes
(Sette et al., 1997), which express the c-kit receptor
(Manova et al., 1990; Horie et al., 1991; Yoshinaga et al.,
1991). As shown for the closely related PDGFb receptor
(Valius et al., 1995), the simultaneous binding to the c-kit
receptor to a particular blend of other signal transduction
molecules might interfere with PLCg1 activation.
Since DAG can be produced by other metabolic routes,
such as phosphatidylcholine hydrolysis by phospholipase
D and conversion of the resulting phosphatidic acid into
DAG by a specific phosphatidate phosphohydrolase (Ex-
ton, 1997), we set out to measure the activity of PLCg1 by
assaying InsPs production, a more specific marker of PIP2
hydrolysis. In agreement with the increase in DAG pro-
duction, we found that coexpression of tr-kit and PLCg1 in
COS cells induced a 2.5-fold increase in InsPs production
compared with cells transfected with PLCg1 alone (Fig. 5
B). Similar to DAG production, transfection of tr-kit
alone induced only a slight increase in InsPs production
versus mock-transfected cells (Fig. 5 B), however, cotrans-
fection with PLCg1 amplifies tr-kit–induced InsPs produc-
tion. Western blot analysis of extracts from these cells in-
dicated that similar amounts of PLCg1 were expressed in
the PLCg1 transfected cells (Fig. 5 C). Therefore, the con-
comitant stimulation of DAG and InsPs production in
COS cells coexpressing tr-kit and PLCg1 is likely due to
posttranslational activation, rather than increased expres-
sion, of PLCg1. These results indicate that in COS cells tr-
kit is able to induce activation of PLCg1.
Tr-kit Stimulates Tyrosine Phosphorylation of PLCg1 
in Transfected COS Cells
Since tyrosine phosphorylation is often associated with acti-
vation of PLCg1 (Rhee and Bae, 1997), we tested whether
an increase in phosphotyrosine content of PLCg1 is detect-
able in tr-kit–expressing cells. In cells transfected with a
PLCg1 expression vector alone, PLCg1 was found to be
Table II. Antibodies Against the SH Region of PLCg1 Inhibit 
Tr-kit–induced Parthenogenetic Activation of Mouse Eggs
Sample
No. of
experiments Total eggs
Pronuclei
formed
Percent
activated eggs
Non-injected 3 30 2 6.6**
Tr-kit 3 23 15 65.2
Tr-kit1IgGs 3 33 19 57.5*
Tr-kit1anti-PLCg1bd 4 40 5 12.5**
Tr-kit1anti-PLCg1ct 4 23 12 52.1*
Summary of microinjection experiments using 5 pl of extracts from tr-kit transfected
COS cells (tr-kit) (200–400 mg/ml) plus nonimmune rabbit IgGs (IgGs), or plus an
antibody directed against the entire SH region of PLCg1 (anti-PLCg1bd) or plus an
antibody directed against the COOH terminus of PLCg1 (anti-PLCg1ct) (all the anti-
bodies were at a 10 mg/ml concentration in the injected solution, final concentration
inside the egg was z0.2 mg/ml). Pronuclear formation was scored 4–7 h after micro-
injection by phase-contrast microscopy, and confirmed by Hoechst staining. Statisti-
cal analysis (ANOVA test) was performed using program PSI-plot 3.0 Polysoftware
International (P values vs. tr-kit: *P . 0.2; **P , 0.0001).
Figure 5. Tr-kit stimulates DAG and
InsP production in COS cells coex-
pressing PLCg1. Cells were transfected
with the indicated expression vectors
and labeled with either [3H]arachidonic
acid (A) or [3H]inositol (B) and pro-
cessed as described under Materials
and Methods. (A) DAG content was
measured as cpm incorporated in DAG
versus 103 cpm incorporated in total lip-
ids. (B) InsPs content was measured as
cpm incorporated into InsPs per mg
protein 24 h after transfection. The
data represent the mean 6 SD of three
separate experiments, each performed
in triplicate. (C) Pellets obtained after
TCA precipitation of representative
samples analyzed for InsP production
were resuspended in SDS-PAGE sam-
ple buffer and analyzed in Western blot
(50  mg in each lane) by using either
anti-PLCg1bd or anti-kit antibodies.The Journal of Cell Biology, Volume 142, 1998 1070
already tyrosine-phosphorylated, but a significant increase
in its phosphotyrosine content was observed in tr-kit/PLCg1
cotransfected cells (Fig. 6 A, right panel). We routinely ob-
served an increase in immunoprecipitated PLCg1 from
PLCg1/tr-kit cotransfected cells (Fig. 6 A, left panel), but
this does not reflect higher PLCg1 expression in these cells
as shown by the Western-blot analysis of total cell extracts
(Fig. 6 B, left panel; see also Fig. 5 C). Densitometric analy-
sis indicated that the tyrosine phosphorylation of PLCg1
(normalized for PLCg1 content of the immunoprecipitates)
was approximately threefold higher in tr-kit cotransfected
cells, with respect to cells transfected with PLCg1 alone
(not shown). This effect was selective since tr-kit expression
did not induce a general increase in the tyrosine phosphor-
ylation pattern of total cell extracts (Fig. 6 B, right panel).
PLCg1 Activation Does Not Require a Stable 
Association with Tr-kit
Tr-kit shares with c-kit the 190 COOH-terminal residues
(Rossi et al., 1992), a region thought to mediate the inter-
action of activated c-kit with PLCg1. Indeed, mutation of
tyrosine 936 to phenylalanine in the human c-kit receptor
impairs docking of PLCg1 (Herbst et al., 1995), and this
residue is conserved in mouse tr-kit (tyr161). SCF-induced
autophosphorylation of the c-kit receptor creates docking
sites for several signaling proteins (Herbst et al., 1991; Lev
et al., 1991; Rottapel et al., 1991; Koike et al., 1993; Blume-
Jensen et al., 1994; Herbst et al., 1995), and presumably,
phosphorylation of tyrosine 936 creates a binding site for
the SH2 domains of PLCg1 or of intercalated adaptor pro-
teins. It is therefore conceivable that also tr-kit, if phos-
phorylated on tyr161, can bind to PLCg1.
To test this hypothesis we expressed tr-kit in COS cells
and purified the cell extracts on a GST-PLCg1-SH2SH2SH3
fusion protein bound to glutathione–agarose beads. We
could not detect any binding of tr-kit to the GST-PLCg1
(Fig. 7 A), indicating that tr-kit does not interact directly,
or at least does not stably associate, with PLCg1. Under
these conditions, although tr-kit was efficiently precipi-
tated by the anti–c-kit antibody (not shown), no tyrosine
phosphorylation of tr-kit was detected (Fig. 7, B and C),
even though we cannot rule out the possibility that this
was due to the sensitivity limits of the assay conditions. As
a control for the coprecipitation experiment shown in Fig.
7 A, we used cell extracts from c-kit–expressing COS cells
that had been previously incubated for 10 min with or
without SCF to induce autophosphorylation of the recep-
tor. As expected, SCF induced tyrosine phosphorylation
of the c-kit receptor (Fig. 7, B and C), and c-kit was copuri-
fied with the GST-PLCg1 fusion protein only after SCF
treatment, while almost no receptor was bound in its rest-
ing state (Fig. 7 A) indicating that tyrosine phosphorylated
c-kit binds to PLCg1. Similar results were obtained by im-
munoprecipitation of cell extracts with anti-kit or anti-
PLCg1 antibodies followed by Western blot analysis using
anti-PLCg1 or anti-kit antibodies, respectively (not shown).
Thus, cotransfection experiments in COS cells indicate
that tr-kit stimulates tyrosine phosphorylation and activa-
tion of PLCg1 in the absence of a direct association with it.
Discussion
Entrance of a sperm factor(s) into the egg cytoplasm after
sperm–egg fusion is thought to trigger a series of events
starting with Ca21 release from intracellular stores and
culminating in completion of the meiotic cell cycle and the
onset of embryonic development (Whitaker and Swann,
1993). Recently, it has been reported that activation of
PLCg is required for the sperm-induced Ca21 rise ob-
served in starfish eggs at fertilization, and that the two
SH2 domains of PLCg and their ability to bind phosphoty-
rosines are important for PLCg activation and the onset of
Ca21 rise (Carroll et al., 1997). Here we report that PLCg1
mediates the parthenogenetic activation of mouse eggs in-
duced by microinjection of recombinant tr-kit, a protein
present in the residual cytoplasm of mouse spermatozoa.
The SH3 domain of PLCg1 plays a fundamental role in tr-
kit–induced egg activation, being required for both corti-
cal granule exocytosis and cell cycle resumption. This role
is specific since the SH3 domain of the Grb2 adaptor pro-
tein does not inhibit tr-kit action inside the egg. We also
show that tr-kit is able to activate recombinant PLCg1
when coexpressed in a heterologous system.
Activation of PLC results in hydrolysis of PIP2 with pro-
duction of DAG and InsP3 (Berridge, 1993), and both
these second messengers are likely to play a major role in
mammalian egg activation at fertilization. DAG and/or
synthetic PKC activators are able to trigger resumption of
cell cycle in MII-arrested oocytes (Colonna et al., 1997;
Gallicano et al., 1997a,b). Microinjection of InsP3 into
mammalian eggs is able to trigger Ca21 transients, cortical
granule exocytosis, and pronuclear formation, and micro-
injection of antibodies directed against the InsP3 receptor
blocks sperm-induced egg activation (Miyazaki et al.,
1992, 1993; Xu et al., 1994; Berridge, 1996). Furthermore,
inhibition of PIP2 hydrolysis with the specific PLC inhibi-
Figure 6. Tr-kit stimulates tyrosine phosphorylation of PLCg1 in
transfected COS cells. Cells were transfected with a PLCg1 ex-
pression vector, either alone or together with the tr-kit expres-
sion vector. (A) Cell extracts were immunoprecipitated using a
mixture of anti-PLCg1 antibodies (see Materials and Methods).
Immunoprecipitated proteins were analyzed in Western blot us-
ing either the anti-PLCg1bd antibody (aPLCg1, left panel) or an
anti-phosphotyrosine antibody (aPY, right panel). These images
are representative of six separate experiments, which gave similar
results. (B) Western blot analysis with anti-PLCg1 antibody
(aPLCg1) and anti-phosphotyrosine antibody (aPY) of total cell
extracts (50 mg in each lane) from PLCg1- and PLCg1/tr-kit–
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tor U73122 blocks the sperm-induced Ca21 spiking at fer-
tilization in mouse eggs (Dupont et al., 1996). The present
data, showing that tr-kit acts through activation of PLCg1,
are in agreement with the previous observation that
U73122 blocks parthenogenetic egg activation triggered
by tr-kit (Sette et al., 1997). The whole of these data indi-
cates that tr-sit is a sperm factor that might play a physio-
logical role in triggering early mouse embryonic develop-
ment. Further support to this hypothesis is the observation
that activation of mouse eggs is elicited by microinjection
of an amount of recombinant tr-kit comparable to that
carried by a single mouse sperm.
PLCg1 is activated by tyrosine kinase–dependent path-
ways (Lee and Rhee, 1995; Kamat and Carpenter, 1997;
Rhee and Bae, 1997) and data suggest that tyrosine kinase
activity is involved in egg activation in different species.
Stimulation of artificially expressed RTKs can initiate egg
activation in Xenopus (Yim et al., 1994) and in starfish
eggs (Shilling et al., 1994). Moreover, endogenous soluble
src-related tyrosine kinases are activated shortly after fer-
tilization both in Xenopus and in sea urchin (Sato et al.,
1996; Kinsey, 1996). In addition, a membrane-associated
c-abl–related tyrosine kinase is also activated at fertilization
in sea urchin eggs (Moore and Kinsey, 1994). Although
the activation of these tyrosine kinases does not always
precede the Ca21 rise, these data indicate that tyrosine
phosphorylation is involved in the early events of fertiliza-
tion. Furthermore, the involvement of PLCg in Ca21 rise
at fertilization in starfish eggs (Carroll et al., 1997) sug-
gests that one or more tyrosine kinases play a role in the
upstream signaling pathway at fertilization in several spe-
cies. Indeed, experiments with specific inhibitors have
shown that tyrosine kinase activity is important for both
block of polyspermy and late events of starfish egg activa-
tion (Moore and Kinsey, 1995). In the mouse, it has been
shown that inhibitors of both tyrosine kinases and PLC
can impair very early events, such as sperm-induced Ca21
spiking, associated with egg activation at fertilization (Du-
pont et al., 1996).
Although tr-kit lacks an ATP-binding site, and thus it
should not present intrinsic tyrosine kinase activity (Rossi
et al., 1992), the possibility exists that tr-kit interacts with
either RTKs or non-receptor tyrosine kinases (NRTKs)
present in the egg, which in turn phosphorylate tr-kit itself,
or other proteins mediating PLCg1 activation. The full-
length c-kit RTK is present in ovulated mouse oocytes
(Manova et al., 1990; Horie et al., 1991; Yoshinaga et al.,
1991); however, we have previously shown that SCF fails
to induce cortical granule exocytosis, meiosis resumption
and pronuclear formation in MII-arrested oocytes (Sette
et al., 1997). In agreement with those observations, we
show here that the SCF-stimulated c-kit receptor binds
PLCg1 but does not stimulate its enzymatic activity in
transfected COS cells, as previously reported in other cel-
lular systems (Lev et al., 1991; Koike et al., 1993; Blume-
Jensen et al., 1994, Kozawa et al., 1997). The results herein
presented also indicate that tr-kit is able to stimulate both
DAG and InsPs production when coexpressed with PLCg1
in COS cells. Since activation of PIP2 hydrolysis does not
seem to require a stable physical interaction between tr-kit
and PLCg1, intercalated proteins may mediate the activa-
tion of PLCg1.
Figure 7. Tr-kit does not stably associate with
PLCg1. (A) COS cells were transfected with no
DNA (mock), or 20 mg/dish pCMV5-c-kit (c-kit),
or 20 mg/dish pCMV5-tr-kit (tr-kit). C-kit–trans-
fected cells were incubated for the final 10 min
with or without 100 ng/ml SCF. Cell extracts were
either analyzed immediately in Western blot (50
mg in each lane) with an anti-kit antibody (right
side of the panel), or incubated for 2 h with a
GST-PLCg1-SH2SH2SH3 fusion protein linked
to glutathione–agarose beads. Proteins bound to
the beads were eluted as described under Materi-
als and Methods and analyzed in Western blot us-
ing an anti-kit antibody (left side of the panel). (B)
Cells were transfected as described in A with tr-
kit or c-kit expression vectors. Cell extracts were
immunoprecipitated using an anti-kit antibody
preadsorbed to protein A–Sepharose beads. Im-
munoprecipitated proteins were analyzed in
Western blot using an anti-phosphotyrosine anti-
body. The band recognized by the anti-phospho-
tyrosine antibody with a molecular size similar to
the one expected for tr-kit is present in all the
samples, regardless of tr-kit presence, indicating
that this band is due to a different tyrosine-phos-
phorylated protein present in the anti-kit immu-
noprecipitates from COS cells. (C) Cell extracts
(50 mg) from the same samples shown in B were
analyzed in Western blot using an anti-kit anti-
body. All panels are representative of at least
three separate experiments.The Journal of Cell Biology, Volume 142, 1998 1072
The SH region of PLCg1 plays an essential role in tr-kit–
mediated activation of mouse eggs, as shown by direct com-
petition experiments with either a GST-PLCg1-SH2SH2SH3
fusion protein or an antibody specifically directed against
this region of the enzyme. Since a GST-PLCg1-SH2SH2
fusion protein inhibits sperm-induced activation of starfish
eggs (Carroll et al., 1997), our results suggest that SH-medi-
ated activation of PLCg1 is an evolutionary conserved
mechanism of egg activation. On the other hand, a GST-
PLCg1-SH3 fusion protein is much more effective than a
GST-PLCg1-SH2SH2 fusion protein in inhibiting tr-kit ac-
tion in mouse eggs. These results are somehow surprising,
since the interaction of the SH2 domains of PLCg1 with
phosphotyrosine residues present in activated RTKs or
NRTKs is thought to be an essential step for tyrosine
phosphorylation, translocation, and activation of PLCg1
(Lee and Rhee, 1995; Kamat and Carpenter, 1997; Rhee
and Bae, 1997).
Tyrosine phosphorylation of PLCg1 has been shown to
correlate with activation of the enzyme (Kim et al., 1991).
We found that, although PLCg1 is already tyrosine-phos-
phorylated when overexpressed in COS cells, coexpres-
sion of tr-kit induces an increase in PLCg1 phosphoty-
rosine content together with activation of PIP2 hydrolysis.
Since we have observed that the SH3 domain instead of
the SH2 domains competes for PLCg1 activation in mouse
eggs, it is possible that additional mechanisms, beside ty-
rosine phosphorylation of PLCg1, are involved in the reg-
ulation of the activity of the enzyme by tr-kit. Indeed, al-
ternative routes of PLCg1 activation have been described
(Rhee and Bae, 1997). For instance, activation of tyrosine
phosphorylated PLCg1 by PDGF in a fibroblast cell line
requires interaction of the pleckstrin homology (PH) do-
main of the enzyme with phosphatidylinositol 3,4,5-tris-
phosphate (PIP3) (Falasca et al., 1998). Moreover, activa-
tion of the T cell receptor causes phosphorylation of
PLCg1, but enzyme activation also requires tyrosine phos-
phorylation of Grb2-associated proteins (Motto et al.,
1996). Ultimately, cytosolic PLCg1 has to reach the partic-
ulate compartments of the cell to exert its enzymatic func-
tion. Translocation of PLCg1 to the membrane and/or the
cytoskeleton might bring the enzyme in close proximity to
other agents, such as phosphatidic acid (Jones and Car-
penter, 1993), arachidonic acid in concert with microtu-
bule-associated tau proteins (Hwang et al., 1996), and PIP3
(Bae et al., 1998; Falasca et al., 1998), which have been re-
ported to stimulate its hydrolytic activity also indepen-
dently from tyrosine phosphorylation. The SH3 domain of
PLCg1 has been shown to direct the enzyme to the cyto-
skeleton in proximity of the plasma membrane (Bar-Sagi et
al., 1993), whereas the PH domain is required for the sta-
ble interaction of PLCg1 with membrane lipids (Falasca et
al., 1998). According to this model, our data suggest that
tr-kit triggers activation of PLCg1 by allowing its interac-
tion with effector proteins in the particulate compartment
of the egg via the SH3 domain.
The SH3 domain might also be directly involved in the
modulation of PLCg1 enzymatic activity. Indeed, microin-
jection of a catalytically inactive PLCg1 into quiescent
NIH3T3 fibroblasts induces a mitogenic response, and the
SH3 domain of the protein is required for this effect
(Huang et al., 1995), suggesting that the SH3 domain of
PLCg1 is the target of inhibitory proteins. Titration of
these proteins with exogenous PLCg1-SH3 domains might
allow activation of endogenous PLCg1, leading to the mi-
togenic response. Deletion experiments suggest that the
SH region of PLCg1 exerts an inhibitory role on the en-
zyme, probably impairing the correct folding of the two X
and Y catalytic domains (Horstman et al., 1996). Presum-
ably, tyrosine phosphorylation of the enzyme produces a
conformational modification and relieves this negative in-
fluence (Kamat and Carpenter, 1997). However, it is possi-
ble that other interactions within the SH region, such as
binding of proteins to the SH3 domain, are able to induce
similar modifications and derepress PLCg1 enzyme activ-
ity. Intercalated proteins might mediate the interaction be-
tween tr-kit and PLCg1 causing the consequent activation
of the enzyme. Indeed, it is known that SH2-containing,
tyrosine-phosphorylated, adaptor proteins, such as the Syp
tyrosine phosphatase, can indirectly couple other signaling
proteins to tyrosine-phosphorylated RTKs (Li et al.,
1994). Tyrosine phosphorylation induced by tr-kit interac-
tion with a kinase present in the egg cytoplasm might cre-
ate docking sites for intercalated adaptor proteins, which
in turn may activate PLCg1 by association with its SH3 do-
main.
Recent findings highlight the importance of SH3 do-
mains in cell signaling. In Xenopus oocytes, the ras-GAP
pathway is involved in germinal vesicle breakdown, and it
has been shown that both an antibody directed against the
SH3 domain of GAP, or peptides encompassing this re-
gion of the enzyme, are able to block germinal vesicle
breakdown induced by oncogenic ras (Duchesne et al.,
1993). The role of SH3 domains in regulating enzyme ac-
tivity has been demonstrated in the case of some NRTKs.
Interaction of proline-rich targets with the SH3 domain of
src-related kinases results in enzyme activation, as demon-
strated for Nef-mediated activation of Hck (Moarefi et al.,
1997). Furthermore, the SH3 domain of Itk (a Tec-related
kinase) interacts with a proline-rich region of the enzyme
resulting in intramolecular inhibition, suggesting that
binding of other proline-rich proteins to this SH3 domain
might result in Itk activation (Andreotti et al., 1997).
Experiments are underway to identify proteins possibly
interacting with tr-kit and PLCg1 inside the egg cytoplasm
and to investigate the physiological role played by tr-kit at
fertilization. Mutagenesis experiments will clarify whether
the phosphotransferase domain, or discrete tyrosine resi-
dues, or other structural elements present in tr-kit are in-
volved in PLCg1 stimulation and consequent egg activation.
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